Atlas Trials

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Clinical trial NCT04491942 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04491942
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical CarcinomaAdvanced Endometrial CarcinomaAdvanced Esophageal CarcinomaAdvanced Gastric CarcinomaAdvanced Head and Neck CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Lung Small Cell CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian CarcinomaAdvanced Penile Carcinoma
Start date
2021-08-25
Primary completion
2027-06-30
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.